معرفی
Sandra Jacobs is an Assistant Professor at the Faculty of Medicine, KU Leuven, specializing in Pediatric Oncology within the Department of Oncology. Her research focuses on neurocognitive outcomes and treatment optimization for pediatric brain tumor survivors, integrating immuno-oncology and radiotherapy studies.
- Key affiliations: LKI - KU Leuven Cancer Institute
- Leadership roles: Head of Pediatric Oncology, Council member (Faculty of Medicine, Department of Oncology)
Her research spans neurocognitive functioning, radiotherapy-induced neurotoxicity, and immuno-oncology in pediatric brain tumors. Recent projects include translational studies on midline gliomas, proton therapy effects on the developing connectome, and development of patient-derived cancer models.
Publications highlight collaborations in pediatric neuro-oncology, with a focus on diffuse midline gliomas, ONC201 therapy, and neurocognitive interventions. She contributes to understanding endocrine sequelae post-craniopharyngioma treatment and BCOR gene alterations in CNS tumors.
As a promotor or co-promotor, she leads studies on neurocognitive impacts of pediatric brain tumors, immuno-oncology matchmakers for gliomas, and radiotherapy optimization. Current projects run until 2029, with a focus on data-driven precision medicine and proton therapy effects.
Jacobs is part of the Council of the Faculty of Medicine and Department of Oncology, advocating for pediatric oncology advancements. She contributes to teaching modules in pediatrics and clinical reasoning, reflecting her commitment to academic training.